“Long-Term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s44. Accessed May 9, 2026. https://skin.dermsquared.com/skin/article/view/1395.